FDA Investigator Shalonda C Clifford

Shalonda C Clifford has inspections in 3 countries as of 24 Aug 2023. Shalonda C Clifford has collaborated with a combinined 1996 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
49
Last Inspection Date:
24 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
100006726
Country:
United States of America, Peru, Canada
Co-Investigator(s):
Adam J Taylor, Alan M Barker, Alecia L Marson, Amanda E Lewin, PhD, Ana E Morales, Andrace Lde Yampert, Andrew A Hoopes, April L Young, Brian D Nicholson, Bruce H Mccullough, Carl J Montgomery, Carolyn A Warren, Chery Grandinetti, Christina A Miller, Claudette D Brooks, Connie L Richard, Constance L Richard, Constance Lrichard Math, Corey K Reno, Courtney R Tiegs, Debra Boyd Seale, Debra I Love, Debra L Boyd Seale, Denise L Burosh, Diane T Reindl, Dr. Jason R Caballero, Dr. Zhou Chen (nmi), MD PhD, Edward E Lockwood (EEL), Emily S Mcgann, Eric A Breselow, Gamal A Norton, Gerald E Scholze, Gordon T Wales, Gregory W Smith, Howard A Burmester, Ivan E Reyes, Jacob W Reynolds, James P Duggan, James W Plucinski, Janis R Armedoriz, Jasjeet K Sekhon, Jeanne J Chiu, Jeanne J Thai, Jeffry A Bernhardt, Jennifer C Adams, Jennifer C Johnson, Jennifer Guttuso, Jesse A Vazquez, Jesse P Romenesko, Jessica L Barr, Jessica L Johnson, Joel D Hustedt, John Misock, Joseph A Piechocki, Justin A Boyd, Kara A Scheibner, PhD, Karen Emasley Joseph, Karen M Montgomery (KMM), Katherine A Clarke Girolamo, Kathleen S Tormey, Kathryn M Mogen, Keith C Rindahl, Kia L Copeland, Kimberly Lewandowski Walker, Kristy E Zuroski, Lauren A Crivellone, Lauren N Howard, Lequita M Mayhew, Liliya V Bubiy, Linda V Weyer, Lisa Hayka, Lisa M Lopez, Marcia A Worley, Margaret Torres Vazquez, Marie A Fadden, Melissa I Michurski, Melissa J Holz, Michele L Glendenning, Michele Perry Williams, Michelle J Glembin, Nicholas P Diorio, Nicholas Z Lu, Nicole C Shokatz, Nicole S Williams, Rafael Padilla, Richard Jay Tucker, RS, Richard M Willey, Robert J Ham, Russell K Riley, Sandra A Hughes, Sandra D Wilson, Sandra D Wilson Newby, Sarah A Palmer, Sharon K Thoma, PharmD, Sherri J Jackson, Soyinka S Eneng, State Agency, Sullan, Susan D Yuscius, Susan Yuscius, Suzanne M Crotty, Tamara M Qtami, Tamara Qtami, Tara M Humfeld, Tenzin Jangchup, Uruaku A Obasi, Wendy A Good, William D Sherman, Yiyue Zhang (nmi), PhD, Yuanyuan Li

Shalonda C Clifford's Documents

Publish Date Document Type Title
October, 2015 FDA 483 Nancy Sweitzer - Form 483, 2015-10-30
April, 2019 EIR Azazuddin A. Ahmed, MD - EIR, 2019-04-30
October, 2015 FDA 483 Response Nancy Sweitzer - Form 483R, 2015-10-16
April, 2019 FDA 483 Azazuddin A. Ahmed, MD - Form 483, 2019-04-30
October, 2015 EIR Nancy Sweitzer - EIR, 2015-09-30
February, 2020 FDA 483 Copley Memorial Hospital - Form 483, 2020-02-10
November, 2018 EIR AbbVie Inc. - EIR, 2018-11-16
October, 2015 FDA 483 Rockline Industries - Form 483, 2015-10-06
April, 2019 EIR AVADEL LEGACY PHARMACEUTICALS, LLC - EIR, 2019-04-24
July, 2016 FDA 483 Response Chemrite Copac, Inc. - Form 483R, 2016-08-04
October, 2019 FDA 483 Richard Bernstein, MD, PhD - Form 483, 2019-10-10
March, 2016 FDA 483 Chemrite Copac, Inc. - Form 483, 2016-03-24
April, 2018 FDA 483 Asthma and Allergy Center of Chicago SC - Form 483, 2018-04-23
January, 2017 FDA 483 Grace Analytical Laboratory, Inc - Form 483, 2017-01-30
November, 2015 FDA 483 Bell Pharmaceuticals, Inc. - Form 483, 2015-11-20
March, 2019 FDA 483 Sufit, Robert, M.D. - Form 483, 2019-03-04
September, 2015 FDA 483 Uriel Pharmacy - Form 483, 2015-09-03
March, 2018 FDA 483 Charles River Laboratories, Inc- IL - Form 483, 2018-03-08
September, 2018 EIR Charles River Laboratories Ashland, LLC - EIR, 2018-09-14
July, 2016 FDA 483 Chemrite Copac, Inc. - Form 483, 2016-07-15
October, 2015 EIR Rockline Industries - EIR, 2015-10-06
February, 2020 FDA 483 William J. Gradishar, M.D. - Form 483, 2020-02-28
June, 2019 FDA 483 MercyOne North Iowa Medical Center IRB - Form 483, 2019-06-21

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more